Chinese regulators have intensified their crackdown on insurers’ use of high-risk, high-return products, which are often used to fund corporate deals.
中國監管機構加大了對保險公司利用高風險高回報產品的打擊，這些產品往往被用于企業交易。
您已閱讀5%（192字），剩余95%（3993字）包含更多重要信息，訂閱以繼續探索完整內容，并享受更多專屬服務。